Vascular safety of erenumab for migraine prevention

OBJECTIVE: To examine the cardiovascular, cerebrovascular, and peripheral vascular safety of erenumab across migraine prevention studies. METHODS: Vascular adverse events (AEs) and blood pressure data were integrated across 4 double-blind, placebo-controlled studies of erenumab and their open-label...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurology
Main Authors: Kudrow, David, Pascual, Julio, Winner, Paul K., Dodick, David W., Tepper, Stewart J., Reuter, Uwe, Hong, Frank, Klatt, Jan, Zhang, Feng, Cheng, Sunfa, Picard, Hernan, Eisele, Osa, Wang, Julie, Latham, Jonathan N., Mikol, Daniel D.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7080286/
https://ncbi.nlm.nih.gov/pubmed/31852816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000008743
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados